Search Results 841-850 of 16473 for Crohns disease

1. Filgotinib In Long-Term Extension Study Of Adults With Crohn's Disease - Mayo Clinic

   ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

2. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

   Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

3. An Extension Study Monitoring The Safety Of Patients With Crohn's Disease Previously Enrolled In The Etrolizumab Phase III Study GA29144 - Mayo Clinic

   ... Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144. ... Participant eligibility includes age, gender, type and stage of ...

4. Digestive Diseases Clinical Trials - Medical Professionals - Mayo Clinic

   The aim of this study is to test the validity of the current question database in a large cohort of children with Inflammatory Bowel Disease (IBD) in several ...

5. Magnetic resonance enterography - Mayo Clinic

   MR enterography often is used for Crohn's disease because it shows the full thickness of the bowel wall and tissues outside the bowel. MR enterography may show ...

6. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

   Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

7. Digestive Diseases Clinical Trials - Medical Professionals - Mayo Clinic

   The aim of this study is to test the validity of the current question database in a large cohort of children with Inflammatory Bowel Disease (IBD) in several ...

8. Inflammatory bowel disease biobank research update - Mayo Clinic

   Researchers from Mayo Clinic's inflammatory bowel disease (IBD) biobank are hopeful that serologic and genetic markers will help them develop therapeutic ...

9. Safety And Efficacy Of GS-5745 In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

   This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of ABT-494 For The Induction Of Symptomatic And Endoscopic Remission In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Immunomodulators Or Anti-TNF Therapy - Mayo Clinic

    To determine the efficacy and safety of multiple doses of ABT-494 in subjects with moderately to severely active Crohn's Disease with a history of inadequate ...